Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment (WalkCog-MCI)
Primary Purpose
Cognitive Impairment
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cognitive Remediation Therapy Group
Walking Intervention (WI) Group
Combination Group
Healthy Living Group
Sponsored by

About this trial
This is an interventional other trial for Cognitive Impairment
Eligibility Criteria
Inclusion Criteria:
- Men and women meeting all criteria listed below will be included in the study:
- Subjects between 65-85 years of age inclusive
- Subjects with Short Physical Performance Battery of 10 or greater
- Subjects averaging less than 5,000 steps per day
- Subjects with Mini Mental State Exam 25-28, inclusive
- Subjects with normal for age physical-neurological exam
- Subjects able to walk a city block without a walking aid
- Written Informed Consent obtained PRIOR to performing any study procedures
Exclusion Criteria:
- Subjects with difficult walking due to pain or posture
- Subjects with difficulty in using computer due to significant visual and/or fine motor impairment
- Subjects with large weight loss (>15 Kilogram) in the last 12 months
- Subjects with geriatric depression scale > 9.
- Subjects with Malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled
- Subjects with abnormal electrocardiogram results. These include: a resting heart rate below 40 bpm or above 100 bpm, previously unknown and/or untreated atrial fibrillation or flutter, evidence of a third degree A-V block, a previously undocumented left bundle branch block, S-T segment depression of greater than 2 mm, evidence of a previous MI, or any other findings that in the clinical judgment of the medical investigator preclude participation in an exercise intervention.
- Subjects with shortness of breath, exertional angina, uncontrolled high blood pressure or any other chronic medical condition deemed by the physician to preclude participation in an exercise intervention.
- Subjects with any other medical condition or disease that is life-threatening or that can interfere with, or be aggravated by, exercise.
- Subjects who currently smoke.
Sites / Locations
- Pennington Biomedical Research Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Experimental
Arm Label
Cognitive Remediation Therapy Group
Walking Intervention Group
Combination Group
Healthy Living Group
Arm Description
30 minute Cognitive Remediation Therapy and 60 minute Healthy Living Class three time per week
60 minutes of walking and 30 minutes of reading stimulation three times a week
30 minutes of Cognitive Remediation therapy and 60 minutes of walking three times a week
60 minute Healthy Living Class and 30 minutes of reading stimulation three times a week.
Outcomes
Primary Outcome Measures
Effects of interventions on cognition
Standard psychometric tests will be used to measure cognition
Secondary Outcome Measures
Effects of interventions on gait
Standard laboratory assessments and accelerometers will be used to measure gait.
Full Information
NCT ID
NCT01801943
First Posted
February 26, 2013
Last Updated
September 21, 2022
Sponsor
Pennington Biomedical Research Center
1. Study Identification
Unique Protocol Identification Number
NCT01801943
Brief Title
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment
Acronym
WalkCog-MCI
Official Title
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment
Study Type
Interventional
2. Study Status
Record Verification Date
June 2014
Overall Recruitment Status
Terminated
Why Stopped
participants are no longer being examined or receiving intervention
Study Start Date
February 2013 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
November 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pennington Biomedical Research Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the effects of a coordinated intervention of cognitive remediation training (CRT) and walking intervention on cognition and gait in the elderly.
Detailed Description
This is a single blind randomized study designed to understand the effects of different interventions, walking interventions and cognitive remediation in particular, towards cognition and gait in the elderly. The study uses a 4 arm approach consisting of 4 intervention groups, with each intervention lasting for 12 weeks. The investigators will investigate the effect of each intervention towards cognitive function and gait. All interventions will be conducted on site at the Pennington Biomedical Research Center, and will be focused on determining the effects of different combinations of walking, cognitive remediation, healthy living courses, and reading. Cognitive measures will include objective clinical measures related to dementia, and the gait analysis will include in clinic and "free living" measures related to falls.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cognitive Impairment
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
8. Arms, Groups, and Interventions
Arm Title
Cognitive Remediation Therapy Group
Arm Type
Experimental
Arm Description
30 minute Cognitive Remediation Therapy and 60 minute Healthy Living Class three time per week
Arm Title
Walking Intervention Group
Arm Type
Experimental
Arm Description
60 minutes of walking and 30 minutes of reading stimulation three times a week
Arm Title
Combination Group
Arm Type
Experimental
Arm Description
30 minutes of Cognitive Remediation therapy and 60 minutes of walking three times a week
Arm Title
Healthy Living Group
Arm Type
Experimental
Arm Description
60 minute Healthy Living Class and 30 minutes of reading stimulation three times a week.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Remediation Therapy Group
Intervention Description
30 min Cognitive Remediation Therapy + 60 Min Healthy Living class 3x week
Intervention Type
Behavioral
Intervention Name(s)
Walking Intervention (WI) Group
Intervention Description
60 min Walking Intervention + 30 min low interface reading 3x week
Intervention Type
Behavioral
Intervention Name(s)
Combination Group
Intervention Description
30 min Cognitive Remediation Therapy + 60 min Walking Intervention 3x week
Intervention Type
Behavioral
Intervention Name(s)
Healthy Living Group
Intervention Description
60 Min Healthy Living class + 30 min low interface reading 3x week
Primary Outcome Measure Information:
Title
Effects of interventions on cognition
Description
Standard psychometric tests will be used to measure cognition
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Effects of interventions on gait
Description
Standard laboratory assessments and accelerometers will be used to measure gait.
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Men and women meeting all criteria listed below will be included in the study:
Subjects between 65-85 years of age inclusive
Subjects with Short Physical Performance Battery of 10 or greater
Subjects averaging less than 5,000 steps per day
Subjects with Mini Mental State Exam 25-28, inclusive
Subjects with normal for age physical-neurological exam
Subjects able to walk a city block without a walking aid
Written Informed Consent obtained PRIOR to performing any study procedures
Exclusion Criteria:
Subjects with difficult walking due to pain or posture
Subjects with difficulty in using computer due to significant visual and/or fine motor impairment
Subjects with large weight loss (>15 Kilogram) in the last 12 months
Subjects with geriatric depression scale > 9.
Subjects with Malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled
Subjects with abnormal electrocardiogram results. These include: a resting heart rate below 40 bpm or above 100 bpm, previously unknown and/or untreated atrial fibrillation or flutter, evidence of a third degree A-V block, a previously undocumented left bundle branch block, S-T segment depression of greater than 2 mm, evidence of a previous MI, or any other findings that in the clinical judgment of the medical investigator preclude participation in an exercise intervention.
Subjects with shortness of breath, exertional angina, uncontrolled high blood pressure or any other chronic medical condition deemed by the physician to preclude participation in an exercise intervention.
Subjects with any other medical condition or disease that is life-threatening or that can interfere with, or be aggravated by, exercise.
Subjects who currently smoke.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeffrey Keller, PhD
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pennington Biomedical Research Center
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70808
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment
We'll reach out to this number within 24 hrs